{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:43:13Z","timestamp":1774536193294,"version":"3.50.1"},"reference-count":36,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","award":["ESRC Impact Grant at Edinburgh University"],"award-info":[{"award-number":["ESRC Impact Grant at Edinburgh University"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","award":["RES-145-28-0002"],"award-info":[{"award-number":["RES-145-28-0002"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Technology Analysis & Strategic Management"],"published-print":{"date-parts":[[2021,3,4]]},"DOI":"10.1080\/09537325.2019.1631449","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T09:25:03Z","timestamp":1560763503000},"page":"307-319","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Policy support for disruptive innovation in the life sciences"],"prefix":"10.1080","volume":"33","author":[{"given":"Joyce","family":"Tait","sequence":"first","affiliation":[{"name":"Innogen Institute and Global Academy of Agriculture and Food Security, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3838-3724","authenticated-orcid":false,"given":"David","family":"Wield","sequence":"additional","affiliation":[{"name":"Innogen Institute, Open University, Milton Keynes, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"key":"CIT0001","author":"Banda G.","year":"2019","journal-title":"Technology Analysis and Strategic Management"},{"key":"CIT0002","unstructured":"Cambridge Consultants. 2018. \u201cBuilding the Business of Biodesign: The Synthetic Biology Industry is Ready to Change Gear.\u201d Workshop Report. https:\/\/www.cambridgeconsultants.com\/synbio\/building-business-biodesign."},{"key":"CIT0003","unstructured":"Chambers, G., A. Dreisin, and M. Pragnell. 2015. \u201cThe British Bioeconomy: An Assessment of the Impact of the Bioeconomy on the UK Economy.\u201d Capital Economics, Report to BBSRC. http:\/\/www.bbsrc.ac.uk\/documents\/capital-economics-british-bioeconomy-report-11-june-2015\/."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1080\/09537320600624063"},{"key":"CIT0005","unstructured":"Christensen, C. M., M. Raynor, and R. McDonald. 2015. \u201cWhat is Disruptive Innovation?\u201d Harvard Business Review, December, Reprint R1512B. https:\/\/hbr.org\/2015\/12\/what-is-disruptive-innovation."},{"key":"CIT0006","first-page":"1","author":"Christensen C.","year":"2017","journal-title":"Industry Horizons"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0008","unstructured":"HM Government. 2017. \u201cIndustrial Strategy: Building a Britain Fit for the Future.\u201d November, Cm 9528. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/662541\/industrial-strategy-white-paper-print-version.pdf."},{"key":"CIT0009","unstructured":"HM Government. 2018. \u201cGrowing the Bioeconomy: A National Bioeconomy Strategy to 2030.\u201d Department for Business, Energy and Industrial Strategy, December 5, 35. https:\/\/www.gov.uk\/government\/publications\/bioeconomy-strategy-2018-to-2030."},{"issue":"1","key":"CIT0010","volume":"57","author":"King A. A.","year":"2015","journal-title":"MIT Sloan Management Review"},{"key":"CIT0011","unstructured":"Law, C. 2015. \u201cCould CRISPR Gene Technology be a Disruptive Innovation?\u201d December 3.\u00a0https:\/\/www.linkedin.com\/pulse\/why-crispr-cas9-gene-editing-technology-may-disruptive-robert-law."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511493270"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1080\/09537325.2019.1573983"},{"issue":"4","key":"CIT0014","first-page":"733","volume":"64","author":"Milne C. P.","year":"2009","journal-title":"Food and Drug Law Journal"},{"key":"CIT0015","volume-title":"The New Health Bioeconomy: R&D Policy and Innovation for the Twenty-first Century","author":"Mittra J.","year":"2015"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbt.2012.03.003"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbt.2014.07.008"},{"key":"CIT0018","unstructured":"Nuffield Council on Bioethics. 2011. \u201cBiofuels: Ethical Issues.\u201d http:\/\/nuffieldbioethics.org\/wp-content\/uploads\/2014\/07\/Biofuels_ethical_issues_FULL-REPORT_0.pdf."},{"key":"CIT0019","unstructured":"Omidvar, O., M. de Grijs, D. Castle, J. Mittra, A. Rosiello, and J. Tait. 2014. \u201cRegenerative Medicine: Business Models, Venture Capital and the Funding Gap.\u201d Report to ESRC and InnovateUK, October 30. http:\/\/www.innogen.ac.uk\/downloads\/RegenerativeMedicine-BusinessModels-VentureCapital-and-theFundingGap-Oct14.pdf."},{"key":"CIT0020","unstructured":"Rafols, I., and R. Costas. 2012. \u201cReport on the Bibliometric Indicators of Innogen (2002\u20132010).\u201d https:\/\/www.innogen.ac.uk\/reports\/703."},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1080\/713698467"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0023","author":"Scannell J.","year":"2019","journal-title":"Technology Analysis and Strategic Management"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.2217\/pme-2016-0057"},{"key":"CIT0025","unstructured":"Tait, J. 1993. \u201cWritten Evidence on Behalf of ESRC to Report of House of Lords Select Committee on Science and Technology.\u201d Regulation of the United Kingdom Biotechnology Industry and Global Competitiveness, 7th Report, Session 1992\/93, HMSO HL Paper 80-I, London, 187\u2013196."},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1080\/09537320701281524"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0028","unstructured":"Tait, J., G. Banda, and A. Watkins. 2017. \u201cProportionate and Adaptive Governance of Innovative Technologies: A Framework to Guide Policy and Regulatory Decision Making.\u201d Innogen Institute Report to the British Standards Institution. https:\/\/www.innogen.ac.uk\/reports\/1222."},{"key":"CIT0029","unstructured":"Tait, J., A. Bruce, J. Mittra, J. Purves, and J. Scannell. 2014. \u201cIndependent Review on Anti-microbial Resistance Regulation\/Innovation Interactions and the Development of Antimicrobial Drugs and Diagnostics for Human and Animal Diseases: Main Report.\u201d Report to ESRC for the O\u2019Neill Commission on Antimicrobial Resistance, December 14. http:\/\/www.innogen.ac.uk\/reports\/946."},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1068\/c0615j"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.3152\/147154302781780949"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/0016-3287(92)90032-B"},{"key":"CIT0033","unstructured":"Tait, J., D. Wield, J. Chataway, and A. Bruce. 2007. \u201cHealth Biotechnology to 2030.\u201d Report to OECD International Futures Project, The Bio-Economy to 2030: Designing a Policy Agenda, OECD, Paris, 51. https:\/\/www.oecd.org\/futures\/long-termtechnologicalsocietalchallenges\/40922867.pdf."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0035","volume-title":"Industrialisation of Biology: A Roadmap to Accelerate the Advanced Manufacturing of Chemicals","author":"US NRC","year":"2015"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.techfore.2016.09.025"}],"container-title":["Technology Analysis & Strategic Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09537325.2019.1631449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T23:17:25Z","timestamp":1619911045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09537325.2019.1631449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,4]]}},"alternative-id":["10.1080\/09537325.2019.1631449"],"URL":"https:\/\/doi.org\/10.1080\/09537325.2019.1631449","relation":{},"ISSN":["0953-7325","1465-3990"],"issn-type":[{"value":"0953-7325","type":"print"},{"value":"1465-3990","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ctas20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ctas20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}